Cyteir Leadership
MANAGEMENT
“It is with patients in the forefront of our minds that we work diligently to develop novel gain of function synthetic lethal therapies”
Melinda Anne Lynch Day, PhD - Principal Scientist, Cyteir Therapeutics, Inc.
Melinda Anne Lynch Day, PhD - Principal Scientist, Cyteir Therapeutics, Inc.